Tenaya Therapeutics to Participate in Upcoming Investor Conferences
Tenaya Therapeutics (NASDAQ: TNYA) has announced its participation in two significant industry conferences: the SVB Securities Global Biopharma Conference and Cowen’s 43rd Annual Health Care Conference. The company presentation at the SVB conference is scheduled for February 16, 2023, from 1:00 PM ET to 1:30 PM ET. Additionally, Tenaya will engage in a Genetic Medicines Panel at Cowen’s conference on March 6, 2023, from 10:30 AM ET to 11:30 AM ET. Webcasts for both events will be available on the Investors section of Tenaya’s website. The company aims to address heart disease through innovative therapies.
- None.
- None.
SOUTH SAN FRANCISCO, Calif., Feb. 07, 2023 (GLOBE NEWSWIRE) -- Tenaya Therapeutics, Inc. (NASDAQ: TNYA), a clinical-stage biotechnology company with a mission to discover, develop and deliver potentially curative therapies that address the underlying causes of heart disease, today announced that company management will participate in the SVB Securities Global Biopharma Conference and Cowen’s 43rd Annual Health Care Conference. Details of participation are as follows:
SVB Securities Global Biopharma Conference
Company Presentation
Date: February 16, 2023
Time: 1:00 PM ET – 1:30 PM ET
Cowen’s 43rd Annual Health Care Conference
Genetic Medicines Panel
Date: March 6, 2023
Time: 10:30 AM ET – 11:30 AM ET
A webcast of both events will be available by visiting the Investors section of Tenaya’s website.
About Tenaya Therapeutics
Tenaya Therapeutics is a clinical-stage biotechnology company committed to a bold mission: to discover, develop and deliver potentially curative therapies that address the underlying drivers of heart disease. Founded by leading cardiovascular scientists from Gladstone Institutes and the University of Texas Southwestern Medical Center, Tenaya is developing therapies for rare genetic cardiovascular disorders, as well as for more prevalent heart conditions, through three distinct but interrelated product platforms: Gene Therapy, Cellular Regeneration and Precision Medicine. For more information, visit www.tenayatherapeutics.com.
Contacts
Investors
Michelle Corral
Vice President, Investor Relations and Corporate Communications
Tenaya Therapeutics
IR@tenayathera.com
Media
Wendy Ryan
Ten Bridge Communications
wendy@tenbridgecommunications.com
FAQ
When will Tenaya Therapeutics present at the SVB Securities Global Biopharma Conference?
What is the date and time for Tenaya Therapeutics at Cowen’s 43rd Annual Health Care Conference?
How can I watch the presentations from Tenaya Therapeutics' conference participation?
What is the mission of Tenaya Therapeutics?
What conferences will Tenaya Therapeutics attend in February and March 2023?
